(Q79144759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Biologically active secondary metabolites from myxobacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

Kaempferol-3-glucorhamnoside

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

(1R,3R,6R,8S,10R,11S,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione

1 reference

1 reference

(3S,10R,11S,13R,17R)-8-tert-butyl-6,9,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione

1 reference

inferred from

reverse claim

(1R,3R,6S,8S,10R,11R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione

1 reference

1 reference

1 reference

1 reference

1 reference

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

1 reference

1 reference

luteolin 3'-glucoside

1 reference

inferred from

reverse claim

(1S,4S,8S,9R,11R)-9-tert-butyl-7,9-dihydroxy-3,5,12-trioxatetracyclo[6.6.0.01,11.04,8]tetradecane-2,6,13-trione

1 reference

inferred from

reverse claim

(1R,3S,6S,7S,8R,9S,10R,11R,12R,13R,16R,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Applied Microbiology and Biotechnology

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

H. Reichenbach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14545007

20 March 2024

G. Höfle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14545007

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14545007

20 March 2024

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

https://api.elsevier.com/content/article/PII:073497509390042L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

https://api.elsevier.com/content/article/PII:073497509390042L?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

published in

Biotechnology Advances

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

219-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

Antibiotika aus Gleitenden Bakterien, XV. Myaxalamide A, B, C und D eine Gruppe homologer Antibiotika ausMyxococcus xanthus Mx x12 (Myxobacterales)

19 December 2019

cites work

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198319830702

Antibiotika aus Gleitenden Bakterien, XVII. Myxopyronin A und B – zwei neue Antibiotika ausMyxococcus fulvus Stamm Mx f50

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198319831003

Antibiotika aus Gleitenden Bakterien, XXIII. Stigmatellin A und B — zwei neue Antibiotika ausStigmatella aurantiaca (Myxobacterales)

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198419841202

Antibiotika aus Gleitenden Bakterien, XXIV. Corallopyronin A, B und C – drei neue Antibiotika ausCorallococcus coralloides Cc c127 (Myxobacterales)

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198519850418

Antibiotika aus Gleitenden Bakterien, XXVII. Angiolam A – ein neues Antibiotikum ausAngiococcus disciformis (Myxobacterales)

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198519851016

Antibiotika aus Gleitenden Bakterien, XXXVI. Ein neues Isochinolin-Alkaloid ausMyxococcus xanthus

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198819880519

Antibiotika aus Gleitenden Bakterien, XXXIX. Biosynthese von Sorangicin A in Sorangium cellulosum, So ce12

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198919890155

Antibiotics from gliding bacteria, XLIV. Ambruticins VS: New members of the antifungal ambruticin family fromSorangium cellulosum

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.1991199101161

Antibiotika aus Gleitenden Bakterien, 45. Phenalamide, neue HIV-1-Inhibitoren ausMyxococcus stipitatus Mx s40

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.1992199201112

Antibiotics from Gliding Bacteria, XLVII. Thiangazole: A Novel Inhibitor of HIV-1 fromPolyangium spec.

9 March 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.199219920163

Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C

9 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

New antibiotics, saframycins A, B, C, D and E.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The structure of a novel antitumor antibiotic, saframycin A

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Pigments with antibiotic activity from Myxococcus coralloides

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Biological activity of an antibiotic produced by Myxococcus coralloides

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Purification and partial characterization of an antibiotic produced by Myxococcus coralloides

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Physical map of the Myxococcus xanthus chromosome

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Lysobacter, a New Genus of Nonfruiting, Gliding Bacteria with a High Base Ratio

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

W-7783, a unique antifungal antibiotic

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antifungal agents. 3. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. A divinylcyclopropane-cycloheptadiene rearrangement

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var fulvum. Ester and amide analogues of ambruticin

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antifungal agents. 5. Chemical modification of antibiotics from Polyangium cellulosum var fulvum. Alcohol, ketone, aldehyde and oxime analogs of ambruticin

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol: a reversible blocker of the cell cycle

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Isolation and identification of 2,3-dihydroxybenzoic acid and .N2,N6-di(2,3-dihydroxybenzoyl)-L-lysine formed by iron-deficient Azotobacter vinelandii

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

On the oxidation pathways of the mitochondrial bc1 complex from beef heart. Effects of various inhibitors

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Neuartige Cerebroside aus Cystobacter fuscus (Myxobacterales) [1] / Novel Cerebrosides from Cystobacter fuscus (Myxobacterales) [1]

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

G1499-2, a new quinoline compound isolated from the fermentation broth of Cytophaga johnsonii

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Studies on the mode of action of althiomycin

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Characterization of cytochrome b in the isolated ubiquinol‐cytochrome c2 oxidoreductase from Rhodopseudomonas sphaeroides GA

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales)

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Determination of bacterial ammonia pools using Myxococcus virescens as an example

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Pyrrolnitrin from Myxococcus fulvus (Myxobacterales)

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Piericidin A: a new inhibitor of mitochondrial electron transport

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Chemistry of a new antibiotic: lactivicin

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Cephabacins, new cephem antibiotics of bacterial origin. II. Isolation and characterization.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Function of MglA, a 22-kilodalton protein essential for gliding in Myxococcus xanthus

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Hollow fiber supported gas membrane for in situ removal of ammonium during an antibiotic fermentation

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Computer simulation of the binding of saframycin A to d (GATGCATC)2.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Mammalian mitochondrial mutants selected for resistance to the cytochromeb inhibitors HQNO or myxothiazol

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

msDNA and bacterial reverse transcriptase

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Saframycin Mx1, a new natural saframycin isolated from a myxobacterium

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antibiotika aus Gleitenden Bakterien, XXXVII. Sorangicin A, ein hochwirksames Antibiotikum mit neuartiger Makrolid-Polyether-Struktur ausSorangium cellulosum, So ce12: Spektroskopische Strukturaufklärung, Kristall- und Lösungsstruktur

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Isolation and spectroscopic structure elucidation of sorangicin a, a new type of macrolide-polyether antibiotic from gliding bacteria - XXX.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

PB-5266 A, B and C, new monobactams. II. Physico-chemical properties and chemical structures

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells.

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Structure-activity relationships of saframycins

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Membranes from Myxococcus fulvus (Myxobacterales) containing carotenoid glucosides. I. Isolation and composition

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Steroids from the Myxobacterium Nannocystis exedens

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxochelin A, a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation, physico-chemical and biological properties

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Phenoxan, a new oxazole-pyrone from myxobacteria: production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales)

20 March 2024

100

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Isolation and identification of althiomycin from Cystobacter fuscus (myxobacterales)

20 March 2024

101

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Nannochelins A, B and C, new iron-chelating compounds from Nannocystis exedens (myxobacteria). Production, isolation, physico-chemical and biological properties

20 March 2024

102

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Note: Fluorescence of Myxococcus stipitatus

20 March 2024

103

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Therapeutic Properties of Oral Ambruticin (W7783) in Experimental Pulmonary Coccidioidomycosis of Mice

20 March 2024

105

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C

20 March 2024

106

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Catacandins, novel anticandidal antibiotics of bacterial origin

20 March 2024

109

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. I. Screening of antibiotics-producing myxobacteria and production of megovalicins.

20 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antagonistic effects of Myxococcus xanthus on fungi. II. Isolation and characterization of inhibitory lipid factors

20 March 2024

115

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antibiotic activity of myxobacteria in relation to their bacteriolytic capacity

20 March 2024

116

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Lactivicin, a naturally occurring non-beta-lactam antibiotic having beta-lactam-like action: biological activities and mode of action.

20 March 2024

117

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity.

20 March 2024

120

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization

20 March 2024

121

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Studies on the effect of stigmatellin derivative on cytochrome band the Rieske iron-sulfur cluster of cytochrome c reductase from bovine heart mitochondria

20 March 2024

122

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Lysobactin, a novel antibacterial agent produced by Lysobacter sp. I. Taxonomy, isolation and partial characterization

20 March 2024

123

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Factors Contributing to the Bacteriolytic Effect of Species of Myxococci upon Viable Eubacteria

20 March 2024

125

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol resistance in human mitochondria

20 March 2024

126

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

A wide-spectrum antibiotic produced by a species of Sorangium

20 March 2024

127

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The specificity of bacterial siderophore receptors probed by bioassays

20 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Inhibition of chlororespiration by myxothiazol and antimycin A in Chlamydomonas reinhardtii

20 March 2024

131

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

In vitro and in vivo studies of ambruticin (W7783): new class of antifungal antibiotics

20 March 2024

137

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Ambruticin (W7783), a new antifungal antibiotic

20 March 2024

138

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Resistance of Escherichia coli to rifampicin and sorangicin A - a comparison

20 March 2024

139

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

Myxococcales

140

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Chemical properties of Myxococcus xanthus antibiotic TA

20 March 2024

141

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Bactericidal action of an antibiotic produced by Myxococcus xanthus

20 March 2024

142

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The structure of althiomycin.

20 March 2024

143

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Matamycin, a new antibiotic. II. Isolation and characterization

20 March 2024

147

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

In vitro studies with ambruticin, a new antifungal antibiotic

20 March 2024

148

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

In vivo studies with ambruticin in murine histoplasmosis

20 March 2024

149

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Control of morphogenesis in myxobacteria

20 March 2024

150

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Social and developmental biology of the myxobacteria

20 March 2024

151

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Isolation and characterization of katanosins A and B

20 March 2024

152

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Chitinovorins A, B and C, novel beta-lactam antibiotics of bacterial origin

20 March 2024

153

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Bacterial production of deacetoxycephalosporin C

20 March 2024

157

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Bacterial production of 7-formamidocephalosporins. Isolation and structure determination

20 March 2024

158

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

Q104155167

160

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins

20 March 2024

161

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The mode of action of stigmatellin, a new inhibitor of the cytochrome b-c1 segment of the respiratory chain

20 March 2024

162

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Mitochondrial and nuclear myxothiazol resistance in Saccharomyces cerevisiae.

20 March 2024

163

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol, a new antibiotic interfering with respiration

20 March 2024

164

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of the respiratory chain

20 March 2024

165

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Two substitutions at the same position in the mitochondrial cytochrome b gene of S. cerevisiae induce a mitochondrial myxothiazol resistance and impair the respiratory growth of the mutated strains abbeit maintaining a good electron transfer activit

20 March 2024

167

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Antibiotika aus Gleitenden Bakterien, XXVI. Konstitution und absolute Konfiguration der epimeren Myxovirescine A1 und A2

20 March 2024

168

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Myxothiazol, an antibiotic from Myxococcus fulvus. (myxobacterales) II. Structure elucidation

20 March 2024

172

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Structure of myxovirescin A, a new macrocylic antibiotic from gliding bacteria

20 March 2024

175

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Structure determination of lysobactin, a macrocyclic peptide lactone antibiotic

20 March 2024

176

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Marinactan, antitumor polysaccharide produced by marine bacteria

20 March 2024

177

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.

20 March 2024

178

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Complete inhibition of electron transfer from ubiquinol to cytochrome b by the combined action of antimycin and myxothiazol

20 March 2024

179

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Use of specific inhibitors on the mitochondrial bc1 complex

20 March 2024

180

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The chromone inhibitor stigmatellin--binding to the ubiquinol oxidation center at the C-side of the mitochondrial membrane

20 March 2024

182

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

20 March 2024

The structure of myxin

183

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Electron conduction between b cytochromes of the mitochondrial respiratory chain in the presence of antimycin plus myxothiazol.

20 March 2024

184

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

A Phylogenetic Definition of the Major Eubacterial Taxa

20 March 2024

185

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

The mode of action of antifungal agents: effect of pyrrolnitrin on mitochondrial electron transport.

20 March 2024

186

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Respiratory chain of a pathogenic fungus, Microsporum gypseum: effect of the antifungal agent pyrrolnitrin

20 March 2024

187

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Studies on WB-3559 A,B,C and D, new potent fibrinolytic agents. I. Discovery, identification, isolation and characterization.

20 March 2024

190

1 reference

https://api.crossref.org/works/10.1016/0734-9750(93)90042-L

Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties.

20 March 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.741

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14545007%20AND%20SRC:MED&resulttype=core&format=json